Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Similar documents
2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ADHD STIMULANTS-S(SHC)

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

ACYCLOVIR OINT (CCHP2017)

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Step Therapy Criteria

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

2019 Simply Step Therapy Document

2014 Quantity Limits (QL) Criteria

Step Therapy Medications

2019 GRS Premier Step Therapy Document

2018 Step Therapy FID 18088

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Step Therapy Medications

2018 GRS Premier Step Therapy Document. September 2018 Y0114_18_33177_I_010

ADHD STIMULANTS - SCORE

Step Therapy Requirements. Effective: 11/01/2018

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

ADHD STIMULANTS - SCORE

ALLERGIC CONJUNCTIVITIS AGENTS

Step Therapy Requirements. Effective: 05/01/2018

2018 Step Therapy Criteria

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

Generics. Lead with. Prescription Step Therapy Program

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Aetna Better Health of Illinois Medicaid Formulary Updates

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Drugs That Require Step Therapy (ST) Step Therapy Medications

Step Therapy Information... 4 Prior Authorization Information ACE Inhibitors and ACE Inhibitor Combinations...60 Acne Therapy...

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

Cigna Drug and Biologic Coverage Policy

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

Step Therapy Requirements

Drug Therapy Guidelines

Step Therapy Requirements

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ANTICONVULSANT STEP THERAPY

STEP THERAPY ALGORITHMS PUP Select Formulary

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA

ANTICONVULSANTS. Details

Step Therapy Requirements. Effective: 1/1/2019

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

Step Therapy Criteria

ATYPICAL ANTIPSYCHOTICS

ANTICONVULSANTS. Details

Medications Requiring Prior Authorization for Medical Necessity

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ANTIDIABETIC AGENTS - MISCELLANEOUS

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2017 Step Therapy Criteria

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

Drug Therapy Guidelines

Avoid paying too much for your prescriptions

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Step Therapy Requirements. Effective: 03/01/2015

ANTICONVULSANTS. Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

Medications Requiring Prior Authorization for Medical Necessity

2014 Preferred Drug List An evidence-based pharmacy program that works for you

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

II. UF CLASS REVIEWS NASAL ALLERGY DRUGS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

2018 Step Therapy (ST) Criteria

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

2017 Step Therapy (ST) Criteria

Hospitality Rx Step Therapy

HEALTHTEAM ADVANTAGE PLAN 2017 Step Therapy Criteria Pending CMS Approval

ALLERGIC RHINITIS-NASAL

Transcription:

Plan Year 2016 CCHP Senior Program (HMO) Step Therapy Criteria (ST) Step Therapy: In some cases, CCHP Senior Program (HMO) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, CCHP Senior Program (HMO) may not cover Drug B unless you try Drug A first. If Drug A does not work for you, CCHP Senior Program (HMO) will then cover Drug B. PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT OUR STEP THERAPY CRITERIA. CCHP Senior Program (HMO) is an HMO plan with a Medicare contract. Enrollment in CCHP Senior Program (HMO) depends on contract renewal. Last updated 10/21/2015 Formulary ID: 00016442 Version: 6

2016 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Products Affected ACTONEL TAB 5MG, 30MG, 35MG, 150MG Last Updated 10/21/2015 Criteria Step Therapy requires a trial of alendronate in previous 180 days. 1

APLENZIN TAB 174MG, 348MG, 522MG Step Therapy requires trial of bupropion SR or bupropion Criteria XL in previous 180 days. 2

ARANESP ALBUMIN FREE INJ 100MCG, 150MCG, 200MCG, 300MCG, 500MCG Criteria Step Therapy requires trial of PROCRIT or EPOGEN 3

ARANESP ALBUMIN FREE INJ 25MCG, 40MCG, 60MCG Criteria Step Therapy requires trial of PROCRIT or EPOGEN 4

ARICEPT TAB 23MG Step Therapy requires trial of donepezil 10mg in previous Criteria 180 days. 5

ATELVIA TAB 35MG Step Therapy requires a trial of alendronate in previous 180 Criteria days. 6

AUVI-Q INJ 0.15MG, 0.3MG Step Therapy requires trial of EPIPEN in previous 180 days. Criteria 7

BECONASE AQ NASAL SPRAY 42MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 8

BESIVANCE OPHTH SUSP 0.6% Step Therapy requires trial of one of the following ciprofloxacin, levofloxacin, ofloxacin, VIGAMOX or MOXEZA in previous 180 days. Criteria 9

BONIVA INJ 3MG/3ML Step Therapy requires a trial of alendronate in previous 180 Criteria days. 10

BONIVA TAB 150MG Step Therapy requires a trial of alendronate in previous 180 Criteria days. 11

BRINTELLIX TAB 5MG, 10MG, 20MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 12

budesonide nasal inhaler 32mcg Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 13

DESVENLAFAXINE ER TAB 50MG, 100MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 14

DEXILANT CAP 30MG, 60MG Step Therapy requires trial of omeprazole, lansoprazole orcriteria pantoprazole in previous 180 days. 15

DIFICID TAB 200MG Criteria Step Therapy requires trial of VANCOCIN. 16

donepezil tab 23mg Step Therapy requires trial of donepezil 10mg in previous Criteria 180 days. 17

ENABLEX TAB 7.5MG, 15MG Criteria Step Therapy requires trial of Vesicare OR Myrbetriq in previous 180 days. If request for bethanechol, step not required for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. 18

EPINEPHRINE INJ 0.15MG, 0.3MG Step Therapy requires trial of EPIPEN in previous 180 days. Criteria 19

EXTAVIA INJ Step Therapy requires trial of two of the following: AVONEX, Criteria REBIF or COPAXONE 20

FARXIGA TAB 5MG, 10MG Step Therapy requires trial of ONGLYZA, JANUVIA, JANUMET Criteria or KOMBIGLYZE in previous 180 days. 21

FETZIMA CAP TITRATION PACK Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 22

FETZIMA ER CAP 20MG, 40MG, 80MG, 120MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 23

fluvoxamine ER cap 100mg, 150mg Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 24

gatifloxacin ophth soln 0.5% Step Therapy requires trial of one of the following ciprofloxacin, levofloxacin, ofloxacin, VIGAMOX or MOXEZA in previous 180 days. Criteria 25

GELNIQUE GEL PUMP 3% Criteria Step Therapy requires trial of Vesicare OR Myrbetriq in previous 180 days. If request for bethanechol, step not required for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. 26

ibandronate inj 3mg/3ml Step Therapy requires a trial of alendronate in previous 180 Criteria days. 27

ibandronate tab 150mg Step Therapy requires a trial of alendronate in previous 180 Criteria days. 28

JARDIANCE TAB 10MG, 25MG Step Therapy requires trial of ONGLYZA, JANUVIA, JANUMET Criteria or KOMBIGLYZE in previous 180 days. 29

KHEDEZLA TAB 50MG, 100MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 30

METROGEL 1% Criteria Step Therapy requires trial of FINACEA. 31

NORITATE CREAM 1% Criteria Step Therapy requires trial of FINACEA. 32

OMNARIS NASAL SPRAY 50MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 33

OXYTROL PATCH 3.9MG Criteria Step Therapy requires trial of Vesicare OR Myrbetriq in previous 180 days. If request for bethanechol, step not required for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. 34

PANCREAZE CAP (ALL STRENGTHS) Step Therapy requires trial of CREON in previous 180 days. Criteria 35

PENTASA CAP 250MG, 500MG Step Therapy requires trial of one of the following ASACOL, Criteria DELZICOL or LIALDA in previous 180 days. 36

PERTZYE CAP (ALL STRENGTHS) Step Therapy requires trial of CREON in previous 180 days. Criteria 37

PEXEVA TAB 10MG, 20MG, 30MG, 40MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 38

PRISTIQ TAB 25MG, 50MG, 100MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 39

QNASL CHILDRENS NASAL SPRAY 40MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 40

QNASL NASAL SPRAY 80MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 41

RHINOCORT AQUA NASAL SPRAY 32MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 42

risedronate sodium DR tab 35mg Step Therapy requires a trial of alendronate in previous 180 Criteria days. 43

risedronate sodium tab 5mg, 30mg, 35mg, 150mg Step Therapy requires a trial of alendronate in previous 180 Criteria days. 44

TOVIAZ TAB 4MG, 8MG Criteria Step Therapy requires trial of Vesicare OR Myrbetriq in previous 180 days. If request for bethanechol, step not required for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. 45

ULORIC TAB 40MG, 80MG Step Therapy requires trial of allopurinol in previous 180 days. Criteria 46

ULTRESA CAP (ALL STRENGTHS) Step Therapy requires trial of CREON in previous 180 days. Criteria 47

URECHOLINE TAB 5MG, 10MG, 25MG, 50MG Criteria Step Therapy requires trial of Vesicare OR Myrbetriq in previous 180 days. If request for bethanechol, step not required for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention. 48

VANCOCIN CAP 125MG Criteria Step Therapy requires trial of metronidazole in previous 180 days 49

VANCOCIN CAP 250MG Criteria Step Therapy requires trial of metronidazole in previous 180 days 50

vancomycin cap 125mg, 250mg Criteria Step Therapy requires trial of metronidazole in previous 180 days 51

VERAMYST NASAL SPRAY 27.5MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 52

VIIBRYD TAB 10MG, 20MG, 40MG Criteria Step Therapy requires trial of one of the following generic SSRI's in previous 180 days: sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 53

XIGDUO XR TAB 5-1000MG Step Therapy requires trial of ONGLYZA, JANUVIA, JANUMET Criteria or KOMBIGLYZE in previous 180 days. 54

XIGDUO XR TAB 5-500MG, 10-500MG, 10-1000MG Step Therapy requires trial of ONGLYZA, JANUVIA, JANUMET Criteria or KOMBIGLYZE in previous 180 days. 55

XOPENEX HFA INHALER 45MCG Step Therapy requires trial of VENTOLIN HFA in previous Criteria 180 days. 56

ZENPEP CAP (ALL STRENGTHS) Step Therapy requires trial of CREON in previous 180 days. Criteria 57

ZETONNA NASAL INHALER 37MCG Criteria Patient has tried or was intolerant to TWO (2) of the following agents: flunisolide, fluticasone and NASONEX. trial of ONE (1) of the following agents: flunisolide, fluticasone or NASONEX. BECONASE AQ requires 58

ZIOPTAN OPHTH SOLN 0.0015% Criteria Step Therapy requires trial of latanoprost. 59

ZYMAXID OPHTH SOLN 0.5% Step Therapy requires trial of one of the following ciprofloxacin, levofloxacin, ofloxacin, VIGAMOX or MOXEZA in previous 180 days. Criteria 60